Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-6,571
Closed -$484K 1263
2023
Q2
$484K Sell
6,571
-559
-8% -$37.7K 0.01% 924
2023
Q1
$418K Buy
7,130
+18
+0.3% +$993 0.01% 959
2022
Q4
$359K Buy
7,112
+27
+0.4% +$1.62K 0.01% 995
2022
Q3
$617K Buy
7,085
+4,376
+162% +$460K 0.01% 754
2022
Q2
$308K Buy
2,709
+282
+12% +$32.4K 0.01% 1002
2022
Q1
$314K Buy
2,427
+7
+0.3% +$1.01K 0.01% 1017
2021
Q4
$437K Buy
2,420
+48
+2% +$8.33K 0.01% 956
2021
Q3
$353K Sell
2,372
-331
-12% -$50.7K 0.01% 1006
2021
Q2
$410K Buy
+2,703
New +$376K 0.01% 990

Other funds holding OMCL

Xponance's OMCL Position: Q3 2023 in Review

Xponance sold out of Omnicell (OMCL) in Q3 2023, closing a stake of 6,571 shares — an estimated $484K sold.

Xponance first reported a position in OMCL in Q2 2021 and held it in 9 quarters. The position peaked at $617K in Q3 2022. 312 funds tracked by Wall St. Rank hold OMCL as of Q3 2023.

  • Xponance reported no remaining Omnicell position as of Q3 2023 after selling out during the quarter.
  • Xponance sold 6,571 Omnicell shares in Q3 2023, an estimated $484K.
  • Xponance first reported a position in Omnicell in Q2 2021 and held it in 9 quarters.
  • Xponance's Omnicell position peaked at $617K in Q3 2022.
  • 312 funds tracked by Wall St. Rank held Omnicell as of Q3 2023.

Based on Xponance's 13F filing for Q3 2023, filed 24 Oct 2023.